The Marathon of Hope Cancer Centres Network (MOHCCN), is presently recruiting cancer patients for its new study focusing on "evolving technologies such as genomics and artificial intelligence to study cancer so that the right treatment can be given to the right patient, at the right time." Sponsored by the University Health Network in Toronto, and involving a collaboration between the Princess Margaret Hospital, the Ontario Institute for Cancer Research, and the Terry Fox Research Institute, this observational study, over a 5-year period, aims to develop standard practices "to create a unique shareable dataset of molecular imaging, clinical, and health outcome information on Canadian cancer cases."
To learn more about this trial and the MOHCCN, click here.
No comments:
Post a Comment